151 related articles for article (PubMed ID: 3237715)
21. X-ray crystal structure of the bovine alpha-chymotrypsin/eglin c complex at 2.6 A resolution.
Bolognesi M; Pugliese L; Gatti G; Frigerio F; Coda A; Antolini L; Schnebli HP; Menegatti E; Amiconi G; Ascenzi P
J Mol Recognit; 1990 Aug; 3(4):163-8. PubMed ID: 2278733
[TBL] [Abstract][Full Text] [Related]
22. Refined molecular structure of pig pancreatic alpha-amylase at 2.1 A resolution.
Larson SB; Greenwood A; Cascio D; Day J; McPherson A
J Mol Biol; 1994 Feb; 235(5):1560-84. PubMed ID: 8107092
[TBL] [Abstract][Full Text] [Related]
23. Water molecules participate in proteinase-inhibitor interactions: crystal structures of Leu18, Ala18, and Gly18 variants of turkey ovomucoid inhibitor third domain complexed with Streptomyces griseus proteinase B.
Huang K; Lu W; Anderson S; Laskowski M; James MN
Protein Sci; 1995 Oct; 4(10):1985-97. PubMed ID: 8535235
[TBL] [Abstract][Full Text] [Related]
24. The refined crystallographic structure of a DD-peptidase penicillin-target enzyme at 1.6 A resolution.
Kelly JA; Kuzin AP
J Mol Biol; 1995 Nov; 254(2):223-36. PubMed ID: 7490745
[TBL] [Abstract][Full Text] [Related]
25. Novel inhibitor for prolyl tripeptidyl aminopeptidase from Porphyromonas gingivalis and details of substrate-recognition mechanism.
Xu Y; Nakajima Y; Ito K; Zheng H; Oyama H; Heiser U; Hoffmann T; Gärtner UT; Demuth HU; Yoshimoto T
J Mol Biol; 2008 Jan; 375(3):708-19. PubMed ID: 18042490
[TBL] [Abstract][Full Text] [Related]
26. Complete substitutional analysis of a sunflower trypsin inhibitor with different serine proteases.
Hilpert K; Hansen G; Wessner H; Volkmer-Engert R; Höhne W
J Biochem; 2005 Oct; 138(4):383-90. PubMed ID: 16272132
[TBL] [Abstract][Full Text] [Related]
27. Refinement of the structure of pseudoazurin from Alcaligenes faecalis S-6 at 1.55 A resolution.
Petratos K; Dauter Z; Wilson KS
Acta Crystallogr B; 1988 Dec; 44 ( Pt 6)():628-36. PubMed ID: 3271558
[TBL] [Abstract][Full Text] [Related]
28. Structure-function relationship of serine protease-protein inhibitor interaction.
Otlewski J; Jaskólski M; Buczek O; Cierpicki T; Czapińska H; Krowarsch D; Smalas AO; Stachowiak D; Szpineta A; Dadlez M
Acta Biochim Pol; 2001; 48(2):419-28. PubMed ID: 11732612
[TBL] [Abstract][Full Text] [Related]
29. Human alpha-thrombin inhibition by the active site titrant N alpha-(N,N-dimethylcarbamoyl)-alpha-azalysine p-nitrophenyl ester: a comparative kinetic and X-ray crystallographic study.
Nardini M; Pesce A; Rizzi M; Casale E; Ferraccioli R; Balliano G; Milla P; Ascenzi P; Bolognesi M
J Mol Biol; 1996 May; 258(5):851-9. PubMed ID: 8637015
[TBL] [Abstract][Full Text] [Related]
30. Crystal structure of the stromelysin catalytic domain at 2.0 A resolution: inhibitor-induced conformational changes.
Chen L; Rydel TJ; Gu F; Dunaway CM; Pikul S; Dunham KM; Barnett BL
J Mol Biol; 1999 Oct; 293(3):545-57. PubMed ID: 10543949
[TBL] [Abstract][Full Text] [Related]
31. Affinity and specificity of serine endopeptidase-protein inhibitor interactions. Empirical free energy calculations based on X-ray crystallographic structures.
Krystek S; Stouch T; Novotny J
J Mol Biol; 1993 Dec; 234(3):661-79. PubMed ID: 8254666
[TBL] [Abstract][Full Text] [Related]
32. Synthetic human prion protein octapeptide repeat binds to the proteinase K active site.
Georgieva D; Rypniewski W; Echner H; Perbandt M; Koker M; Clos J; Redecke L; Bredehorst R; Voelter W; Genov N; Betzel C
Biochem Biophys Res Commun; 2004 Dec; 325(4):1406-11. PubMed ID: 15555583
[TBL] [Abstract][Full Text] [Related]
33. Inhibitor-based validation of a homology model of the active-site of tripeptidyl peptidase II.
De Winter H; Breslin H; Miskowski T; Kavash R; Somers M
J Mol Graph Model; 2005 Apr; 23(5):409-18. PubMed ID: 15781183
[TBL] [Abstract][Full Text] [Related]
34. Characterization of a recombinantly expressed proteinase K-like enzyme from a psychrotrophic Serratia sp.
Larsen AN; Moe E; Helland R; Gjellesvik DR; Willassen NP
FEBS J; 2006 Jan; 273(1):47-60. PubMed ID: 16367747
[TBL] [Abstract][Full Text] [Related]
35. Strategy to design peptide inhibitors: structure of a complex of proteinase K with a designed octapeptide inhibitor N-Ac-Pro-Ala-Pro-Phe-DAla-Ala-Ala-Ala-NH2 at 2.5 A resolution.
Saxena AK; Singh TP; Peters K; Fittkau S; Betzel C
Protein Sci; 1996 Dec; 5(12):2453-8. PubMed ID: 8976553
[TBL] [Abstract][Full Text] [Related]
36. Autolysis and inhibition of proteinase K, a subtilisin-related serine proteinase isolated from the fungus Tritirachium album Limber.
Bajorath J; Saenger W; Pal GP
Biochim Biophys Acta; 1988 May; 954(2):176-82. PubMed ID: 3284591
[TBL] [Abstract][Full Text] [Related]
37. Design of P1' and P3' residues of trivalent thrombin inhibitors and their crystal structures.
Slon-Usakiewicz JJ; Sivaraman J; Li Y; Cygler M; Konishi Y
Biochemistry; 2000 Mar; 39(9):2384-91. PubMed ID: 10694407
[TBL] [Abstract][Full Text] [Related]
38. Refined crystal structure of porcine class Pi glutathione S-transferase (pGST P1-1) at 2.1 A resolution.
Dirr H; Reinemer P; Huber R
J Mol Biol; 1994 Oct; 243(1):72-92. PubMed ID: 7932743
[TBL] [Abstract][Full Text] [Related]
39. Structure/function analysis of a dUTPase: catalytic mechanism of a potential chemotherapeutic target.
Harris JM; McIntosh EM; Muscat GE
J Mol Biol; 1999 Apr; 288(2):275-87. PubMed ID: 10329142
[TBL] [Abstract][Full Text] [Related]
40. The 2.0 A crystal structure and substrate specificity of the KDEL-tailed cysteine endopeptidase functioning in programmed cell death of Ricinus communis endosperm.
Than ME; Helm M; Simpson DJ; Lottspeich F; Huber R; Gietl C
J Mol Biol; 2004 Mar; 336(5):1103-16. PubMed ID: 15037072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
